Ozempic Just Got Cheap Enough to Change the Entire World episode artwork

EPISODE · Mar 27, 2026 · 10 MIN

Ozempic Just Got Cheap Enough to Change the Entire World

from Good Revenue

A blockbuster drug collapsing from $1,000 to $15 looks like a pricing story. It isn’t. It is a signal that control over human behavior, demand, and consumption is shifting fast. Between generics, new science, and AI-driven optimization, entire industries tied to addiction, food, and habit-driven spending may face structural decline. This episode breaks down why this disruption was inevitable and what happens next.CHAPTERS00:00 $1,000 drug drops to $15 overnight00:30 The real story behind the price collapse00:56 Patent cliff and global generics surge01:40 Pricing pressure spreads beyond India02:30 Who controls the pipeline03:40 New research changes expectations05:20 AI enters dosing and drug discovery06:30 This becomes an economic story07:00 Workforce and GDP implications08:15 Spending shifts across industries09:15 What breaks nextSOURCES- Affordable GLP-1 Options Emerging in India and Beyond (CNBC): https://www.cnbc.com/2026/03/23/novo-nordisk-cheap-weight-loss-drugs-india-generic-ozempic-wegovy-semaglutide.html- Global Impact of Ozempic Generics Expanding to China and Canada (NYT): https://www.nytimes.com/2026/03/19/health/ozempic-wegovy-generic-india-china-canada.html- Worldwide Reactions to Cheaper GLP-1 Drugs (BBC Analysis): https://www.bbc.com/news/articles/cx2g4411en3o- AI Optimizing Weight Loss Outcomes: https://www.sciencedirect.com/science/article/abs/pii/S2405457725003821- Personalized Semaglutide Therapy with Artificial Intelligence: https://ai.jmir.org/2026/1/e86960- Breakthroughs in GLP-1 Drug Engineering: https://www.sciencedirect.com/science/article/pii/S1359644625000467- Cutting-Edge Ozempic Alternatives in Research: https://www.nature.com/articles/s41586-025-08683-y- Stanford Research on New Ozempic Rivals: https://med.stanford.edu/news/all-news/2025/03/ozempic-rival.html- GLP-1 Demand and Consumer Purchase Data (Numerator Report): https://www.numerator.com/press/numerator-glp-1-hub-reveals-purchase-trends-from-30k-consumers/- Marketing Shifts in the Weight-Loss Drug Space: https://journals.sagepub.com/doi/10.1177/00222437251412834- Ozempic Frenzy: What’s Coming Next in Weight-Loss Drugs (WSJ): https://www.wsj.com/health/pharma/weight-loss-drug-frenzy-whats-here-and-whats-likely-coming-next-a84ef28b?mod=hp_lead_pos7- GLP-1 Market Expansion Across Global Economies: https://www.arabnews.com/node/2637254/world- New Findings on Stopping Ozempic and Mounjaro Use (Science Daily): https://www.sciencedaily.com/releases/2026/03/260319044648.htm#:~:text=03/260319044648.htm- GLP-1 Insights from Griffith University Study (Science Daily): https://www.sciencedaily.com/releases/2026/03/260322020250.htmFOLLOW GOOD REVENUE ON YOUTUBE! Or wherever you get your podcasts:YouTube: https://www.youtube.com/channel/UCHrhuWbpYnUwrR75H2Ip4yQ Spotify: https://open.spotify.com/show/44me6PABSQ0k0GfphM70auApple Podcast: https://podcasts.apple.com/us/podcast/good-revenue/id1707461473  Hosted on Acast. See acast.com/privacy for more information.

A blockbuster drug collapsing from $1,000 to $15 looks like a pricing story. It isn’t. It is a signal that control over human behavior, demand, and consumption is shifting fast. Between generics, new science, and AI-driven optimization, entire industries tied to addiction, food, and habit-driven spending may face structural decline. This episode breaks down why this disruption was inevitable and what happens next.CHAPTERS00:00 $1,000 drug drops to $15 overnight00:30 The real story behind the price collapse00:56 Patent cliff and global generics surge01:40 Pricing pressure spreads beyond India02:30 Who controls the pipeline03:40 New research changes expectations05:20 AI enters dosing and drug discovery06:30 This becomes an economic story07:00 Workforce and GDP implications08:15 Spending shifts across industries09:15 What breaks nextSOURCES- Affordable GLP-1 Options Emerging in India and Beyond (CNBC): https://www.cnbc.com/2026/03/23/novo-nordisk-cheap-weight-loss-drugs-india-generic-ozempic-wegovy-semaglutide.html- Global Impact of Ozempic Generics Expanding to China and Canada (NYT): https://www.nytimes.com/2026/03/19/health/ozempic-wegovy-generic-india-china-canada.html- Worldwide Reactions to Cheaper GLP-1 Drugs (BBC Analysis): https://www.bbc.com/news/articles/cx2g4411en3o- AI Optimizing Weight Loss Outcomes: https://www.sciencedirect.com/science/article/abs/pii/S2405457725003821- Personalized Semaglutide Therapy with Artificial Intelligence: https://ai.jmir.org/2026/1/e86960- Breakthroughs in GLP-1 Drug Engineering: https://www.sciencedirect.com/science/article/pii/S1359644625000467- Cutting-Edge Ozempic Alternatives in Research: https://www.nature.com/articles/s41586-025-08683-y- Stanford Research on New Ozempic Rivals: https://med.stanford.edu/news/all-news/2025/03/ozempic-rival.html- GLP-1 Demand and Consumer Purchase Data (Numerator Report): https://www.numerator.com/press/numerator-glp-1-hub-reveals-purchase-trends-from-30k-consumers/- Marketing Shifts in the Weight-Loss Drug Space: https://journals.sagepub.com/doi/10.1177/00222437251412834- Ozempic Frenzy: What’s Coming Next in Weight-Loss Drugs (WSJ): https://www.wsj.com/health/pharma/weight-loss-drug-frenzy-whats-here-and-whats-likely-coming-next-a84ef28b?mod=hp_lead_pos7- GLP-1 Market Expansion Across Global Economies: https://www.arabnews.com/node/2637254/world- New Findings on Stopping Ozempic and Mounjaro Use (Science Daily): https://www.sciencedaily.com/releases/2026/03/260319044648.htm#:~:text=03/260319044648.htm- GLP-1 Insights from Griffith University Study (Science Daily): https://www.sciencedaily.com/releases/2026/03/260322020250.htmFOLLOW GOOD REVENUE ON YOUTUBE! Or wherever you get your podcasts:YouTube: https://www.youtube.com/channel/UCHrhuWbpYnUwrR75H2Ip4yQ Spotify: https://open.spotify.com/show/44me6PABSQ0k0GfphM70auApple Podcast: https://podcasts.apple.com/us/podcast/good-revenue/id1707461473  Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Ozempic Just Got Cheap Enough to Change the Entire World

0:00 10:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Tao Te Ching by Laozi (Author), Stephen Mitchell (Full Audiobook) Laozi Lao-tzu's Tao Te Ching, or Book of the Way, is the classic manual on the art of living, and one of the wonders of the world. In eighty-one brief chapters, the Tao Te Ching looks at the basic predicament of being alive and gives advice that imparts balance and perspective, a serene and generous spirit. This book is about wisdom in action. It teaches how to work for the good with the effortless skill that comes from being in accord with the Tao (the basic principle of the universe) and applies equally to good government and sexual love; to child rearing, business, and ecology.Stephen Mitchell's bestselling version has been widely acclaimed as a gift to contemporary culture. Growth Triggers Luis Diaz Discover how to use your podcast to generate leads, sales, and influence in any market.On this show Luis shares his best tested and proven secrets, tips, and strategies from launching over 300 podcasts in over a dozen different niches and generating over 59 Million Downloads for his clients.Learn how to increase your podcast listenership, create multiple new revenue streams with your podcast, sell more of your core offer and build a show that gives you leverage and authority in your space. From picking the right monetization strategy for your podcast to learning how to position your podcast in a crowded market on Apple and Spotify; this is show is the ultimate marketing and sales resource for online business owners who want to know what works with podcasting.Get in touch over on Instagram <a target="_blank" rel="noopener noreferrer nofollow" class="link" href="https://www.instagram.com/luisr Changemakers Mastercard Welcome to Changemakers, a Mastercard storylab series about employees who have become a force for good in local communities. Join hosts Anthony Venutolo and Vicki Hyman in discovering who they are and how they are making a difference in the lives of people around the world. Well & Good with Art Green Roar Collective Well & Good is a meeting place where listeners can pick the brains of some of the world’s leading health and wellbeing authorities. Hosted by wellbeing advocate Art Green, we talk with a broad range of experts to learn wellness techniques in all different aspects of this fast-developing space. Exceptional guests break down scientific breakthroughs, lived experience and the latest research into relatable, actionable tips, arming listeners with the tools and knowledge to reach their health potential.

Frequently Asked Questions

How long is this episode of Good Revenue?

This episode is 10 minutes long.

When was this Good Revenue episode published?

This episode was published on March 27, 2026.

What is this episode about?

A blockbuster drug collapsing from $1,000 to $15 looks like a pricing story. It isn’t. It is a signal that control over human behavior, demand, and consumption is shifting fast. Between generics, new science, and AI-driven optimization, entire...

Can I download this Good Revenue episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!